Curtò L. Temozolomide therapy: Focus on patients with pituitary carcinoma. J Neurosci Rural Pract. 2016;7(3):335–336.
Halevy C, Whitelaw BC. How effective is temozolomide for treating pituitary tumours and when should it be used? Pituitary. 2017;20(2):261-266.
Hansen TM, Batra S, Lim M, et al. Invasive adenoma and pituitary carcinoma: a SEER database analysis. Neurosurg Rev. 2014;37(2):279-285; discussion 285-286.
Heaney AP. Pituitary carcinoma: Difficult diagnosis and treatment. J Clin Endocrinol Metab. 2011; 96(12): 3649–3660.
Ji Y, Vogel RI, Lou E. Temozolomide treatment of pituitary carcinomas and atypical adenomas: Systematic review of case reports. Neurooncol Pract. 2016;3(3):188-195.
Raverot G, Burman P, McCormack A, et al; European Society of Endocrinology. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur J Endocrinol. 2018;178(1):G1-G24.